Mitomycin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00305 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 87 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | osteoclastic giant cell tumor of pancreas | KG + DL |
| 2 | solid pseudopapillary carcinoma of pancreas | KG + DL |
| 3 | pancreatic carcinoma with mixed differentiation | KG + DL |
| 4 | pancreatic intraductal papillary-mucinous carcinoma | KG + DL |
| 5 | mixed ductal-endocrine carcinoma of pancreas | KG + DL |
| 6 | pancreatic signet ring cell adenocarcinoma | KG + DL |
| 7 | undifferentiated pancreatic carcinoma | KG + DL |
| 8 | malignant exocrine pancreas neoplasm | KG + DL |
| 9 | pancreatic intraductal papillary-mucinous neoplasm | KG + DL |
| 10 | pancreatic acinar cell cystadenocarcinoma | KG + DL |
| 11 | pancreatic serous cystadenocarcinoma | KG + DL |
| 12 | pancreatic mucinous cystadenocarcinoma | KG + DL |
| 13 | colloid carcinoma of the pancreas | KG + DL |
| 14 | sickle cell-hemoglobin d disease syndrome | KG + DL |
| 15 | hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | KG + DL |
| 16 | sickle cell-hemoglobin c disease syndrome | KG + DL |
| 17 | sickle cell-beta-thalassemia disease syndrome | KG + DL |
| 18 | sickle cell-hemoglobin E disease syndrome | KG + DL |
| 19 | female breast carcinoma | KG + DL |
| 20 | pancreatic mucinous cystadenoma | KG + DL |
| 21 | primary pulmonary lymphoma | KG + DL |
| 22 | well-differentiated fetal adenocarcinoma of the lung | KG + DL |
| 23 | malignant pleural mesothelioma | KG + DL |
| 24 | pulmonary blastoma | KG + DL |
| 25 | small cell lung carcinoma | KG + DL |
| 26 | T-lymphoblastic lymphoma | KG + DL |
| 27 | malignant epithelioid mesothelioma | KG + DL |
| 28 | sarcomatoid mesothelioma | KG + DL |
| 29 | odontogenic cyst | KG + DL |
| 30 | cervical neuroblastoma | KG + DL |
| 31 | nasopharyngeal teratoma | KG + DL |
| 32 | tumor of testis and paratestis | KG + DL |
| 33 | schwannoma of jugular foramen | KG + DL |
| 34 | pre-malignant neoplasm | KG + DL |
| 35 | benign neoplasm of floor of mouth | KG + DL |
| 36 | benign neoplasm of tongue | KG + DL |
| 37 | cystic neoplasm | KG + DL |
| 38 | benign neoplasm of hypopharynx | KG + DL |
| 39 | epiglottis neoplasm | KG + DL |
| 40 | inner ear neoplasm | KG + DL |
| 41 | thyroglossal duct cyst | KG + DL |
| 42 | vestibulocochlear nerve neoplasm | KG + DL |
| 43 | nasal cavity inverting papilloma | KG + DL |
| 44 | mesenchymoma | KG + DL |
| 45 | jugular foramen meningioma | KG + DL |
| 46 | bronchial adenomas/carcinoids childhood | KG + DL |
| 47 | non-seminomatous lesion | KG + DL |
| 48 | ductal or ductular proliferation | KG + DL |
| 49 | chondroid hamartoma | KG + DL |
| 50 | benign neoplasm of nasal cavity | KG + DL |
(Showing top 50 of 87 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.